$PNTG
Pennant Group, Inc.

2023 Q4 Form 10-Q Financial Statement

#000176640023000127 Filed on November 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $146.0M $140.2M
YoY Change 17.08% 18.46%
Cost Of Revenue $116.6M $111.4M
YoY Change 19.99% 19.67%
Gross Profit $29.37M $28.80M
YoY Change 6.8% 14.01%
Gross Profit Margin 20.12% 20.54%
Selling, General & Admin $21.13M $9.417M
YoY Change 11.35% -44.15%
% of Gross Profit 71.95% 32.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.313M $1.321M
YoY Change 7.36% 6.19%
% of Gross Profit 4.47% 4.59%
Operating Expenses $22.45M $9.417M
YoY Change 11.11% -48.0%
Operating Profit $6.926M $7.061M
YoY Change -5.14% -1.16%
Interest Expense -$1.569M $1.496M
YoY Change 19.95% 41.4%
% of Operating Profit -22.65% 21.19%
Other Income/Expense, Net $311.0K -$37.00K
YoY Change 1536.84% 105.56%
Pretax Income $6.309M $5.528M
YoY Change 23.83% -8.9%
Income Tax $1.780M $1.066M
% Of Pretax Income 28.21% 19.28%
Net Earnings $4.349M $4.383M
YoY Change 25.19% -9.27%
Net Earnings / Revenue 2.98% 3.13%
Basic Earnings Per Share $0.15
Diluted Earnings Per Share $0.14 $0.15
COMMON SHARES
Basic Shares Outstanding 29.93M shares 29.85M shares
Diluted Shares Outstanding 30.21M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.059M $3.400M
YoY Change 191.44% 15.06%
Cash & Equivalents $6.059M $3.383M
Short-Term Investments
Other Short-Term Assets $12.90M $9.500M
YoY Change -29.59% -22.91%
Inventory
Prepaid Expenses
Receivables $61.12M $59.35M
Other Receivables $0.00 $0.00
Total Short-Term Assets $80.08M $72.20M
YoY Change 8.47% 7.94%
LONG-TERM ASSETS
Property, Plant & Equipment $28.60M $27.98M
YoY Change 7.43% 17.02%
Goodwill $91.01M $86.13M
YoY Change 14.49% 8.77%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.337M $8.100M
YoY Change -26.45% -41.23%
Total Long-Term Assets $459.6M $448.1M
YoY Change 4.86% 2.31%
TOTAL ASSETS
Total Short-Term Assets $80.08M $72.20M
Total Long-Term Assets $459.6M $448.1M
Total Assets $539.7M $520.3M
YoY Change 5.38% 3.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.84M $12.18M
YoY Change -20.56% -4.48%
Accrued Expenses $51.81M $47.70M
YoY Change 22.12% 9.37%
Deferred Revenue $1.658M $1.786M
YoY Change 4.15% 13.76%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $71.55M $68.76M
YoY Change 1.85% -5.5%
LONG-TERM LIABILITIES
Long-Term Debt $63.91M $53.80M
YoY Change 1.63% -3.52%
Other Long-Term Liabilities $8.262M $8.679M
YoY Change 31.54% 42.33%
Total Long-Term Liabilities $8.262M $8.679M
YoY Change 31.54% 42.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $71.55M $68.76M
Total Long-Term Liabilities $8.262M $8.679M
Total Liabilities $394.2M $380.8M
YoY Change 2.0% -0.84%
SHAREHOLDERS EQUITY
Retained Earnings $34.66M $30.31M
YoY Change 62.86% 70.21%
Common Stock $29.00K $29.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $140.3M $134.5M
YoY Change
Total Liabilities & Shareholders Equity $539.7M $520.3M
YoY Change 5.38% 3.06%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $4.349M $4.383M
YoY Change 25.19% -9.27%
Depreciation, Depletion And Amortization $1.313M $1.321M
YoY Change 7.36% 6.19%
Cash From Operating Activities $5.180M $12.38M
YoY Change -231.81% 53.31%
INVESTING ACTIVITIES
Capital Expenditures $2.359M $1.780M
YoY Change -36.99% -169.45%
Acquisitions
YoY Change
Other Investing Activities -$10.29M -$4.580M
YoY Change 3124.76% -48.32%
Cash From Investing Activities -$12.65M -$6.350M
YoY Change 211.25% -44.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.14M -5.480M
YoY Change 42.5% -276.43%
NET CHANGE
Cash From Operating Activities 5.180M 12.38M
Cash From Investing Activities -12.65M -6.350M
Cash From Financing Activities 10.14M -5.480M
Net Change In Cash 2.676M 550.0K
YoY Change -405.48% -324.49%
FREE CASH FLOW
Cash From Operating Activities $5.180M $12.38M
Capital Expenditures $2.359M $1.780M
Free Cash Flow $2.821M $10.60M
YoY Change -136.76% -0.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
112384000 usd
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
94680000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9417000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5879000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1323000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1251000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1000 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-4000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-6713000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
133131000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
111206000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7061000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7144000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
1496000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1058000 usd
us-gaap Interest Expense
InterestExpense
4355000 usd
us-gaap Interest Expense
InterestExpense
2508000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1533000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5528000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6068000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1066000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4994000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
163000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4383000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4831000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29912000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29335000 shares
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
125657000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1850000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
147000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1367000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
203000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
129224000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2797000 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
125000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1303000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
249000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
133698000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
90000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117932000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
10006000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
9391000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1076000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
4462000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30206000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30172000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4383000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1341000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
18000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
139519000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
1014000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
144000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2440000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2676000 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
80000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2380000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
271000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
117987000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4831000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
163000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-2747000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
606000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
120840000 usd
us-gaap Profit Loss
ProfitLoss
9381000 usd
us-gaap Profit Loss
ProfitLoss
3556000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3817000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3677000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
391000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
390000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
218000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
620000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
603000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4011000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2073000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3066000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
752000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5560000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1734000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11387000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1429000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
121000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-140000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-866000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1655000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1376000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1278000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-394000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4333000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6211000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
560000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
485000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27910000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12974000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5746000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10426000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
11662000 usd
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
9680000 usd
pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
168000 usd
pntg Payments For Proceeds From Property Reserve Requirements
PaymentsForProceedsFromPropertyReserveRequirements
70000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17576000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20176000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
131500000 usd
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
82000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
141000000 usd
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
78000000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
470000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
967000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9030000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4967000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1304000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2235000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2079000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5190000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3383000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2955000 usd
us-gaap Interest Paid Net
InterestPaidNet
3997000 usd
us-gaap Interest Paid Net
InterestPaidNet
2114000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
176000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
77000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
27231000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
27092000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9357000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
10326000 usd
pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
5195000 usd
pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
6270000 usd
pntg Adjustment Operating Lease Right Of Use Asset And Operating Lease Liability
AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
0 usd
pntg Adjustment Operating Lease Right Of Use Asset And Operating Lease Liability
AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
-43136000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
680000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1100000 usd
us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. (herein referred to as “Pennant,” the “Company,” “it,” or “its”), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of September 30, 2023, the Company’s subsidiaries operated 103 home health, hospice and home care agencies and 51 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company’s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company’s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated “Company” and “its” assets and activities are not meant to imply, nor should they be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by Pennant.</span></div>
CY2023Q3 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
872000 usd
CY2022Q4 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
1479000 usd
CY2023Q3 pntg State Relief Funds Reduction
StateReliefFundsReduction
923000 usd
pntg State Relief Funds Reduction
StateReliefFundsReduction
3005000 usd
us-gaap Use Of Estimates
UseOfEstimates
The preparation of the Interim Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Interim Financial Statements relate to revenue, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, self-insurance reserves, and income taxes. Actual results could differ from those estimates.
CY2022Q3 pntg State Relief Funds Reduction
StateReliefFundsReduction
734000 usd
pntg State Relief Funds Reduction
StateReliefFundsReduction
1980000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4383000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
4831000 usd
us-gaap Net Income Loss
NetIncomeLoss
9030000 usd
us-gaap Net Income Loss
NetIncomeLoss
3169000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29912000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29335000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29825000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28840000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
294000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
837000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
353000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1342000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30206000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30172000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30178000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30182000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2718000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2278000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1858000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1806000 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
348576000 usd
us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140192000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118350000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
398937000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
60284000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
931000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59353000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140192000 usd
CY2023Q3 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
20647000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
118350000 usd
CY2022Q3 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
16971000 usd
CY2023Q3 pntg Income Loss From Continuing Operations Before Interest Taxes Depreciation And Amortization Rent Costs Acquisition Costs And Stock Based Compensation
IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
20647000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1323000 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
10006000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37000 usd
CY2023Q3 pntg Start Up Activities Costs
StartUpActivitiesCosts
-108000 usd
CY2023Q3 pntg Share Based Compensation Expense And Related Taxes
ShareBasedCompensationExpenseAndRelatedTaxes
1391000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
71000 usd
CY2023Q3 pntg Costs Associated With Transitioning Operations
CostsAssociatedWithTransitioningOperations
10000 usd
CY2023Q3 pntg Unusual Non Recurring Or Redundant Charges
UnusualNonRecurringOrRedundantCharges
1009000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7061000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52483000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
47428000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24500000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20807000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27983000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26621000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
1321000 usd
us-gaap Depreciation
Depreciation
3807000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
1244000 usd
us-gaap Depreciation
Depreciation
3640000 usd
CY2023Q3 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1754000 usd
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
2244000 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1786000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1592000 usd
CY2023Q3 us-gaap Deposit Liability Current
DepositLiabilityCurrent
2657000 usd
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
4315000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1254000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1027000 usd
CY2023Q3 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
872000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
79497000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
6635000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
86132000 usd
CY2023Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
62908000 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
58617000 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2023Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022Q4 pntg Deferred State Relief Funds Current
DeferredStateReliefFundsCurrent
1479000 usd
CY2023Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
4590000 usd
CY2022Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
3546000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2664000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2481000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15577000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16684000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1217000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1608000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
53783000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
62892000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
391000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
130000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
390000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1341000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-2747000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4011000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2073000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
9287000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
36549000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
35195000 usd
CY2023Q3 pntg Number Of Locations
NumberOfLocations
9 location
CY2023Q3 pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
5195000 usd
pntg Non Cash Adjustment Increase Decrease To Right Of Use Assets And Lease Liabilities
NonCashAdjustmentIncreaseDecreaseToRightOfUseAssetsAndLeaseLiabilities
5195000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1876000 usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1590000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
5367000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4463000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
34032000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
33268000 usd
CY2023Q3 pntg Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
281565000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
429896000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
163981000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
265915000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16341000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
249574000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y9M18D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.081
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1066000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1074000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.193
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.177
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3894000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
241000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.293
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.063
CY2023Q3 pntg Number Of Operating Subsidiaries With Reviews Scheduled
NumberOfOperatingSubsidiariesWithReviewsScheduled
9 review
CY2023Q3 pntg Uniform Program Integrity Contractor Suspended Payments
UniformProgramIntegrityContractorSuspendedPayments
5105000 usd
CY2022Q2 pntg Uniform Program Integrity Contractor Sampled And Extrapolated Overpayments
UniformProgramIntegrityContractorSampledAndExtrapolatedOverpayments
1915000 usd
CY2022Q2 pntg Uniform Program Integrity Contractor Number Of Patient Records Under Review
UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview
107 agency
CY2022Q2 pntg Uniform Program Integrity Contractor Period Of Review
UniformProgramIntegrityContractorPeriodOfReview
P10M
CY2023Q3 pntg Uniform Program Integrity Contractor Suspended Payments
UniformProgramIntegrityContractorSuspendedPayments
5105000 usd
CY2023Q3 pntg Uniform Program Integrity Contractor Previously Withheld Amounts
UniformProgramIntegrityContractorPreviouslyWithheldAmounts
3191000 usd
pntg Uniform Program Integrity Contractor Previously Withheld Amounts
UniformProgramIntegrityContractorPreviouslyWithheldAmounts
3222000 usd
CY2022Q2 pntg Uniform Program Integrity Contractor Sampled And Extrapolated Overpayments
UniformProgramIntegrityContractorSampledAndExtrapolatedOverpayments
1915000 usd
CY2023Q3 pntg General And Professional Liability Insurance Retention Limit Per Claim
GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim
150000 usd
CY2023Q3 pntg Corridor As An Additional Out Of Pocket Retention
CorridorAsAnAdditionalOutOfPocketRetention
500000 usd
CY2023Q3 pntg Workers Compensation Insurance Retention Limit Per Claim
WorkersCompensationInsuranceRetentionLimitPerClaim
250000 usd
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares

Files In Submission

Name View Source Status
0001766400-23-000127-index-headers.html Edgar Link pending
0001766400-23-000127-index.html Edgar Link pending
0001766400-23-000127.txt Edgar Link pending
0001766400-23-000127-xbrl.zip Edgar Link pending
ceocert-exhibit311q32023.htm Edgar Link pending
ceocert-exhibit321q32023.htm Edgar Link pending
cfocert-exhibit312q32023.htm Edgar Link pending
cfocert-exhibit322q32023.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pntg-20230930.htm Edgar Link pending
pntg-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pntg-20230930_cal.xml Edgar Link unprocessable
pntg-20230930_def.xml Edgar Link unprocessable
pntg-20230930_lab.xml Edgar Link unprocessable
pntg-20230930_pre.xml Edgar Link unprocessable
pntg-20230930_htm.xml Edgar Link completed
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending